|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-4-1
|
|
pubmed:abstractText |
The aim of this study was to determine the in vitro and in vivo effects of the lytic peptide, hecate, alone and conjugated to a 15-amino-acid fragment of the beta-chain of hCG (hecate-beta hCG) on the ovarian carcinoma cell line NIH: OVCAR-3 and determine the expression of luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptors in cell cultures and tumor tissues.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
45-52
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11925119-Animals,
pubmed-meshheading:11925119-Chorionic Gonadotropin, beta Subunit, Human,
pubmed-meshheading:11925119-Female,
pubmed-meshheading:11925119-Humans,
pubmed-meshheading:11925119-Immunohistochemistry,
pubmed-meshheading:11925119-Melitten,
pubmed-meshheading:11925119-Mice,
pubmed-meshheading:11925119-Mice, Nude,
pubmed-meshheading:11925119-Ovarian Neoplasms,
pubmed-meshheading:11925119-Receptors, LH,
pubmed-meshheading:11925119-Tumor Cells, Cultured,
pubmed-meshheading:11925119-Xenograft Model Antitumor Assays
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo.
|
|
pubmed:affiliation |
Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana 30803, USA. gawronB@pbrc.edu
|
|
pubmed:publicationType |
Journal Article
|
